Telmisartan and Memory loss - a phase IV clinical study of FDA data
Summary:
Memory loss is reported as a side effect among people who take Telmisartan (telmisartan), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Aspirin, and have Relapsing-remitting multiple sclerosis.
The phase IV clinical study analyzes which people have Memory loss when taking Telmisartan. It is created by eHealthMe based on reports of 8,644 people who have side effects when taking Telmisartan from the FDA, and is updated regularly.
What is Telmisartan?
Telmisartan has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 9,163 Telmisartan users. Check the latest studies of Telmisartan.
What is Memory loss?
Memory loss is found to be associated with 2,730 drugs and 4,375 conditions by eHealthMe. Check the latest studies of Memory loss.
8,644 people reported to have side effects when taking Telmisartan.
Among them, 88 people (1.02%) have Memory loss.

Among these 88 people:
How long have people been on Telmisartan when they have Memory loss? *
- < 1 month: 0.0 %
- 1 - 6 months: 100 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Memory loss when taking Telmisartan? *
- female: 54.93 %
- male: 45.07 %
What is the age of people who have Memory loss when taking Telmisartan? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 6.25 %
- 50-59: 22.92 %
- 60+: 70.83 %
What are other drugs people take besides Telmisartan? *
- Aspirin: 41 people, 46.59%
- Vitamin D3: 27 people, 30.68%
- Lamotrigine: 27 people, 30.68%
- Tylenol: 25 people, 28.41%
- Baclofen: 25 people, 28.41%
- Meloxicam: 24 people, 27.27%
- Hydrocortisone: 23 people, 26.14%
- Prolia: 23 people, 26.14%
- Lipitor: 22 people, 25.00%
- Clobetasol Propionate: 21 people, 23.86%
What are other side effects people have besides Memory loss? *
- Weakness: 45 people, 51.14%
- Headache (pain in head): 32 people, 36.36%
- Hypoaesthesia (reduced sense of touch or sensation): 31 people, 35.23%
- Pain In Extremity: 29 people, 32.95%
- Dizziness: 28 people, 31.82%
- Muscle Spasms (muscle contraction): 28 people, 31.82%
- Joint Pain: 28 people, 31.82%
- Depression: 28 people, 31.82%
- Neuropathy Peripheral (surface nerve damage): 27 people, 30.68%
- Gait Disturbance: 25 people, 28.41%
What are the existing conditions these people have? *
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 9 people, 10.23%
- Stress And Anxiety: 8 people, 9.09%
- Depression: 8 people, 9.09%
- Type 2 Diabetes: 5 people, 5.68%
- Back Pain: 5 people, 5.68%
- High Blood Cholesterol: 4 people, 4.55%
- Cerebral Disorder (brain disease): 3 people, 3.41%
- Fatigue (feeling of tiredness): 3 people, 3.41%
- Drowsiness: 3 people, 3.41%
- Pain: 3 people, 3.41%
* Approximation only. Some reports may have incomplete information.
Do you take Telmisartan and have Memory loss?
- Check whether Memory loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Telmisartan:
- Telmisartan (9,163 reports)
Memory loss treatments and more:
- Memory loss (244,444 reports)
How severe was Memory loss and when was it recovered:
Expand to all the drugs that have ingredients of telmisartan:
- Memory loss and drugs with ingredients of telmisartan (358 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Telmisartan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Memory loss:
- Memory loss (2,730 drugs)
Browse all the conditions that are associated with Memory loss:
- Memory loss (4,375 conditions)
Related publications that referenced our studies
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on telmisartan (the active ingredients of Telmisartan) and Telmisartan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Metastatic Renal Cell Carcinoma and Gallstones - 15 seconds ago
- Drug interactions of Lansoprazole and Daliresp - 16 seconds ago
- Hypericum Perforatum vs. Divalproex, side effect and effectiveness comparison - 20 seconds ago
- Could Febuxostat cause Weight Loss? - 23 seconds ago
- Could Percocet cause Dementia? - 23 seconds ago
- Could Frova cause Dizziness? - 25 seconds ago
- Could Morphine Sulfate cause Ear Pain? - 30 seconds ago
- Could Coumadin cause Skin Exfoliation? - 30 seconds ago
- Could Allegra cause Tremor Aggravated? - 36 seconds ago
- Drug interactions of Aleve and Doxycycline - 36 seconds ago